Robert D. Groneberg - Concepedia

Author

Robert D. Groneberg

Array BioPharma (United States)

Also Known As

R. D. GRONEBERG, R. D. Groneberg, Robert D Groneberg, Robert D. Groneberg, Robert Groneberg

Publications

801

Citations

H-Index

Concepts

All Affiliations

Array BioPharma (United States)Amgen (United States)AstraZeneca (Sweden)

About

Robert D. Groneberg is an author at Array BioPharma (United States) specializing in biochemistry, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	12	12	620
2	Medicine	8	8	351
3	Natural Sciences	8	8	453
4	Biomolecular Engineering	5	5	312
5	Engineering	4	4	274

Robert D. Groneberg

Publications

766

Citations

H-Index

Page 1

	Year	Citations
Total synthesis of calicheamicin .gamma.1I. 1. Synthesis of the oligosaccharide fragment Robert D. Groneberg, T. Miyazaki, N. Stylianides, Journal of the American Chemical Society BiosynthesisBioorganic ChemistryEngineeringBiochemistryNatural Sciences	1993	142
Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors C. Todd Eary, Zachary S. Jones, Robert D. Groneberg, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicinePharmacotherapyDrug DevelopmentPharmacology	2007	86
Total synthesis of the oligosaccharide fragment of calicheamicin .gamma.1I K. C. Nicolaou, Robert D. Groneberg, T. Miyazaki, Journal of the American Chemical Society Pharmaceutical ScienceBioorganic ChemistryBiochemistryMedicineNatural Sciences	1990	85
Novel strategy for the construction of the oligosaccharide fragment of calichemicin .gamma.1.alpha.I. Synthesis of the ABC skeleton K. C. Nicolaou, Robert D. Groneberg Journal of the American Chemical Society Abc SkeletonBioorganic ChemistryEngineeringGlycobiologyAltmetric Attention Score	1990	66
Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species Kevin W. Hunt, Adam W. Cook, Ryan J. Watts, Journal of Medicinal Chemistry	2013	58
Synthesis, structure–property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor Peter Bach, Jonas Boström, Kay Brickmann, European Journal of Medicinal Chemistry Molecular PharmacologyPharmaceutical ScienceBiochemistryMedicineP2y12 Receptor	2013	42
Dual Inhibition of Phosphodiesterase 4 and Matrix Metalloproteinases by an (Arylsulfonyl)hydroxamic Acid Template Robert D. Groneberg, Christopher J. Burns, Matthew M. Morrissette, Journal of Medicinal Chemistry Phosphodiesterase 4Altmetric Attention ScoreChemical BiologyEnzymatic ModificationArcola Road	1999	38
Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System Allen A. Thomas, Kevin W. Hunt, Matthew Volgraf, Journal of Medicinal Chemistry 7-Tetrahydropyran-2-yl ChromansPeptide ScienceNeurochemical BiomarkersPharmaceutical ChemistryMolecular Pharmacology	2014	38
Synthesis of the CD and E ring systems of the calicheamicin γ<sub>1</sub><sup>I</sup>oligosaccharide K. C. Nicolaou, Robert D. Groneberg, N. Stylianides, Journal of the Chemical Society Chemical Communications BiosynthesisBioorganic ChemistryN. A. StylianidesBiochemistryT. Miyazaki	1990	34
Methyl 4‐Hydroxy‐5‐iodo‐2,3‐dimethoxy‐6‐methylbenzoate: The Aromatic Fragment of Calichemicin γ. Synthesis, X‐Ray Crystallographic Analysis, and Properties K. C. Nicolaou, Takuma Ebata, N. Stylianides, Angewandte Chemie International Edition in English Aromatic FragmentBioorganic ChemistryMethyl 4‐Hydroxy‐5‐iodo‐2,3‐dimethoxy‐6‐methylbenzoateBenzoate 1Engineering	1988	32

Page 1